Home › Liposarcoma › Tennessee › Nashville
Liposarcoma clinical trials in Nashville, TN
4 studies for Liposarcoma are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
RecruitingPhase 3
- Vanderbilt University/Ingram Cancer Center, Nashville
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
RecruitingPhase 2
- Sarah Cannon Research Institute - Pharmacy, Nashville
- SCRI Oncology Partners, Nashville
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
RecruitingPhase 3
- Vanderbilt University/Ingram Cancer Center, Nashville
Liposarcoma trials in other cities
- Houston, TX11 studies
- New York City, NY7 studies
- Boston, MA7 studies
- St. Louis, MO5 studies
- Queens, NY5 studies
- Chicago, IL5 studies
- Miami, FL4 studies
- Tampa, FL4 studies
- Atlanta, GA4 studies
- Edison, NJ4 studies
- Seattle, WA4 studies
- Gainesville, FL3 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer78 studies
- Metastatic Cancer69 studies
- Colorectal Cancer67 studies
- Cancer (all types)65 studies
- Ovarian Cancer50 studies
- Head and Neck Squamous Cell Carcinoma43 studies
- Prostate Cancer40 studies
- Pancreatic Cancer39 studies
- Lung Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.